Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07142369 · ClinicalTrials.gov registry record · NA
Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines
A NA study, sponsored by Rush University Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT07142369: Clinical Trial NA study, sponsored by Rush University Medical Center.
NCT07142369 is a NA study that has not yet begun recruiting, run by Rush University Medical Center. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07142369, a NA study, has not yet begun recruiting, sponsored by Rush University Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to determine what effects the withdrawal of excess knee joint fluid or the injection of a factor from the blood has on swelling after a sudden anterior cruciate ligament (ACL) rupture of the knee.
Primary Outcome
Breakdown cytokine found in damaged cartilage
Interventions
- PROCEDURE Synovial Fluid withdrawal at the preoperative clinic visit
- PROCEDURE Platelet-Rich Plasma (PRP) preparation and injection
- PROCEDURE Synovial fluid withdrawal at the time of surgery
- PROCEDURE 3mL synovial fluid withdrawn at the preoperative visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2026-09 |
| Est. Completion | 2028-12 |
| Phase | NA |
What is known before NCT07142369 opens enrollment
NCT07142369 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 4 interventions - of which Synovial Fluid withdrawal at the preoperative clinic visit is the first listed.
NCT07142369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07142369 about?
NCT07142369 is a clinical study titled "Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines". The purpose of this study is to determine what effects the withdrawal of excess knee joint fluid or the injection of a factor from the blood has on swelling after a sudden anterior cruciate ligament (ACL) rupture of the knee.
What is the current status of trial NCT07142369?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2026-09. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07142369?
The interventions under investigation include: Synovial Fluid withdrawal at the preoperative clinic visit (PROCEDURE), Platelet-Rich Plasma (PRP) preparation and injection (PROCEDURE), Synovial fluid withdrawal at the time of surgery (PROCEDURE), 3mL synovial fluid withdrawn at the preoperative visit (PROCEDURE).
Who is sponsoring clinical trial NCT07142369?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07142369's enrollment target sits among peer trials
99 920th of 2000 higher than 1,079 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia